With $19 billion in ARR yet still rushing to IPO: the survival gamble behind Anthropic's moment in the spotlight

Why rush to the market?

Anthropic says it now runs roughly $19 billion in annual recurring revenue — a figure CEO Dario Amodei disclosed at a Morgan Stanley TMT conference and one that has the company angling for a $350–$400 billion IPO valuation. So why rush to list? Because revenue alone does not buy you time. It has been reported that Anthropic faces enormous near‑term cash needs to keep pace with OpenAI and Google on model training and that many early investors need an exit. Reportedly, the company has begun preliminary talks with Wall Street banks and is eyeing a Q4 listing, possibly as early as October — not as a celebratory capstone but as a financing lifeline.

A leak, and a credibility wound

Trouble arrived in the form of a configuration error. Bleeping Computer reported that around 3,000 internal files became publicly accessible; Anthropic later confirmed the leak and acknowledged the authenticity of drafts tied to its next‑generation model, codenamed “Capybara” and expected to launch as Claude Mythos. Reportedly, Mythos pursues a different technical path — prioritizing long‑context fidelity and tool‑calling accuracy over raw parameter scaling — and is framed as a “step‑change” aimed at high‑value enterprise use cases such as code, security and research. But the leak did more than expose product strategy: it punctured Anthropic’s core brand promise of “AI safety.” How do you sell secure enterprise contracts when your own R&D documents were left publicly accessible?

Money, dependence and the policy wrinkle

On paper Anthropic’s ARR and enterprise partnerships look like a second‑wave challenger story. In practice the company reportedly burned roughly $12 billion on compute in 2024 alone, with large parts of its cash flow tied to AWS credits from Amazon — itself a major investor — creating a circular “left hand in, right hand out” finance model and a single‑vendor risk. Add an intensifying enterprise price war — OpenAI trimming API prices, Google’s lower‑cost Gemini enterprise — and Anthropic’s high‑ARPU strategy looks fragile. There is, however, a near‑term policy reprieve: a federal judge in Northern California issued a preliminary injunction that paused a Pentagon “supply‑chain risk” exclusion, and it has been reported that Apple’s iOS 27 Extensions includes Claude among early partners — both developments that reduce regulatory and distribution risk, at least temporarily. The coming months will hinge on whether Mythos can deliver measurable, defensible gains over GPT‑4o Advanced and whether Anthropic can translate its headline ARR into durable, profitable growth. If it succeeds, the IPO will be a bold scaling play; if it doesn’t, it will expose how quickly a modern AI challenger can be unseated by costs, leaks and competitors with deeper cloud and silicon ecosystems.